Penumbra, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for PEN, updated each market day.
PEN AI Sentiment
AI predicts Penumbra, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Penumbra, Inc.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Sector
Exchange
Market Cap
$12,931,370,824
Cap Tier
Employees
4,700
Headquarters
ALAMEDA, CA
Listed Since
Sept. 18, 2015
Website
PEN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PEN Volatility
Penumbra, Inc. has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
